A.P. Pharma, Inc. (APPA) Thursday announced the appointment of Jesse Hollingsworth as vice president of sales.
Hollingsworth most recently served as the Senior Director of Group Purchasing Organizations or GPO and Trade Strategy at Dendreon, where he developed and implemented the company's national GPO strategy. He was also responsible for building and managing relationships with top community oncologists for the company.
Prior to his work at Dendreon, Hollingsworth was the Senior Director of Strategic Business Development and Marketing at ION Solutions, an Amerisource Bergen Specialty Group where he focused on GPO, payer and practice solutions.
Earlier, he worked at Amgen, Inc., where, he was the Marketing Director for the oncology business unit, responsible for US reimbursement and access programs for the Neulasta, Neupogen and Vectibix franchises.
Robert Rosen, A.P. Pharma's chief commercial officer, said, "Over the past several months, A.P. Pharma has been focused on recruiting key additions to our management team, and Jesse's experience in oncology sales will provide insights into the sales program for our lead product candidate, APF530.''
APF530 is being developed for the prevention of acute- and delayed-onset chemotherapy-induced nausea and vomiting.
For comments and feedback: editorial@rttnews.com